LIVN - LivaNova PLC logo

LivaNova PLC

LIVN

LivaNova PLC designs and manufactures medical devices in two segments: Cardiopulmonary, offering heart-lung machines and oxygenators, and Neuromodulation, providing therapies for epilepsy and depression. It serves healthcare professionals and institutions globally.

⚕️ Healthcare NASDAQ Listed 1993 $ USD
$1,000 invested 30 years ago →$31,972today

Score Overview

1 Year
Score
Net Growth180.86%
Net TrendGrew
Net Income Consistency—
Rev Growth8.55%
Rev TrendGrew
Revenue Consistency—
5 Years
Score7.5
Net Growth244.37%
Net Trend80%
Net Income Consistency—
Rev Growth45.53%
Rev Trend80%
Revenue Consistency—
10 Years
Score
Net Growth412.23%
Net Trend70%
Net Income Consistency
Rev Growth24.13%
Rev Trend60%
Revenue Consistency
20 Years
Score5.4
Net Growth483.11%
Net Trend65%
Net Income Consistency
Rev Growth11x
Rev Trend70%
Revenue Consistency
30 Years
Score
Net Growth19x
Net Trend64%
Net Income Consistency
Rev Growth1076x
Rev Trend73%
Revenue Consistency
All Time
Score
Net Growth35x
Net Trend58%
Net Income Consistency
Rev Growth3767x
Rev Trend73%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where LivaNova PLC has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • LIVN

2004: 63.3% · 2021: 75.4% · free through 2021 · longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 91.92—
1 Year2025-11-17
$ 53.6471.36%
5 Years2021-11-17
$ 85.966.93%
10 Years2016-11-17
$ 43.24112.58%
20 Years2006-11-17
$ 21.58325.95%
30 Years1996-11-15
$ 2.8831x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 1.50B$ 196M$ 563M
2025$ 1.38B-$ 242M$ 635M
2024$ 1.25B$ 63M$ 428M
2023$ 1.15B$ 17M$ 266M
2022$ 1.02B-$ 86M$ 214M
2021$ 1.03B-$ 135M$ 207M
2020$ 934M-$ 348M$ 252M
2019$ 1.08B-$ 157M$ 61M
2018$ 1.10B-$ 189M$ 47M
2017$ 1.01B-$ 25M$ 93M
2016$ 1.21B-$ 62M$ 39M
2015$ 291M$ 57M$ 119M
2014$ 282M$ 54M$ 128M
2013$ 282M$ 54M$ 128M
2012$ 254M$ 46M$ 135M
2011$ 218M$ 36M$ 96M
2010$ 190M$ 46M$ 89M
2009$ 167M$ 78M$ 85M
2008$ 143M$ 26M$ 54M
2007$ 121M-$ 10M$ 62M
2006$ 130M-$ 51M$ 89M
2005$ 123M-$ 59M$ 92M
2004$ 103M-$ 12M$ 61M
2003$ 110M$ 6M$ 58M
2002$ 104M$ 5M$ 57M
2001$ 70M-$ 26M$ 39M
2000$ 43M$ 43M
1999$ 47M-$ 3M$ 16M
1998$ 29M-$ 12M$ 20M
1997$ 14M-$ 14M$ 200K
1996$ 1M-$ 11M$ 18M
1995$ 1M-$ 10M$ 2M
1994$ 1M-$ 7M$ 6M
IPO1993$ 400K-$ 5M$ 4M
LIVN - LivaNova PLC logo

LivaNova PLC fundamental performance

Between 2020 and 2025, revenue grew from $ 934M to $ 1.38B and net income went from -$ 348M to -$ 242M. Revenue increased in 4 of those 5 years; net income in 4.

Across LivaNova PLC's full reported history, from 1993 to 2025, revenue grew from $ 400K to $ 1.38B and net income went from -$ 5M to -$ 242M. Revenue increased in 73% of the years measured; net income in 58%.

LivaNova PLC currently holds a 20-year HDB Score of 5.4 out of 10. How the HDB Score is calculated.

Membership

Continue LIVN’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,187 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies